Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Metabotropic Glutamate | 2 | 2023 | 233 | 1.460 |
Why?
|
| Benzoxazoles | 3 | 2020 | 86 | 1.300 |
Why?
|
| Coordination Complexes | 2 | 2014 | 82 | 0.940 |
Why?
|
| Thiourea | 1 | 2022 | 67 | 0.900 |
Why?
|
| Radiopharmaceuticals | 3 | 2023 | 2760 | 0.830 |
Why?
|
| Picolines | 1 | 2020 | 16 | 0.790 |
Why?
|
| Chelating Agents | 2 | 2020 | 404 | 0.780 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2018 | 201 | 0.640 |
Why?
|
| Fluorescent Dyes | 4 | 2020 | 1988 | 0.620 |
Why?
|
| Ketones | 3 | 2013 | 180 | 0.570 |
Why?
|
| Manganese | 1 | 2018 | 409 | 0.560 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 663 | 0.540 |
Why?
|
| Zinc Compounds | 1 | 2014 | 39 | 0.530 |
Why?
|
| Diphosphates | 1 | 2014 | 96 | 0.520 |
Why?
|
| Aluminum | 1 | 2014 | 139 | 0.520 |
Why?
|
| Chromium | 1 | 2014 | 133 | 0.510 |
Why?
|
| Fluorine Radioisotopes | 3 | 2023 | 468 | 0.500 |
Why?
|
| Zinc | 2 | 2020 | 695 | 0.490 |
Why?
|
| Alcohols | 1 | 2013 | 90 | 0.470 |
Why?
|
| 4-Butyrolactone | 2 | 2010 | 60 | 0.460 |
Why?
|
| Hydrazines | 1 | 2014 | 231 | 0.460 |
Why?
|
| Aldehydes | 2 | 2010 | 194 | 0.460 |
Why?
|
| Cyclohexylamines | 1 | 2010 | 21 | 0.410 |
Why?
|
| Diamines | 1 | 2010 | 58 | 0.400 |
Why?
|
| Positron-Emission Tomography | 7 | 2023 | 6295 | 0.400 |
Why?
|
| Chalcone | 1 | 2010 | 9 | 0.400 |
Why?
|
| Chalcones | 1 | 2010 | 28 | 0.390 |
Why?
|
| Cyclopentanes | 1 | 2010 | 95 | 0.380 |
Why?
|
| Catalysis | 6 | 2019 | 821 | 0.340 |
Why?
|
| Protons | 1 | 2013 | 1067 | 0.330 |
Why?
|
| Molecular Structure | 6 | 2020 | 1990 | 0.320 |
Why?
|
| Drug Stability | 2 | 2020 | 309 | 0.300 |
Why?
|
| Iron | 1 | 2014 | 1737 | 0.290 |
Why?
|
| Schiff Bases | 2 | 2016 | 26 | 0.290 |
Why?
|
| Contrast Media | 2 | 2019 | 5278 | 0.290 |
Why?
|
| Nitriles | 1 | 2010 | 950 | 0.280 |
Why?
|
| Ligands | 3 | 2022 | 3334 | 0.280 |
Why?
|
| Furans | 2 | 2019 | 195 | 0.270 |
Why?
|
| Drug Design | 2 | 2020 | 1107 | 0.230 |
Why?
|
| Brain | 4 | 2022 | 25281 | 0.230 |
Why?
|
| Stereoisomerism | 4 | 2013 | 654 | 0.220 |
Why?
|
| Automation | 1 | 2023 | 595 | 0.190 |
Why?
|
| Microsomes, Liver | 1 | 2020 | 186 | 0.190 |
Why?
|
| Fluorescence | 2 | 2020 | 771 | 0.190 |
Why?
|
| Copper Radioisotopes | 1 | 2020 | 89 | 0.190 |
Why?
|
| Integrin beta3 | 1 | 2020 | 119 | 0.190 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2019 | 27 | 0.180 |
Why?
|
| Transition Elements | 1 | 2019 | 16 | 0.180 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 3249 | 0.180 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2019 | 59 | 0.180 |
Why?
|
| Indoles | 2 | 2019 | 1859 | 0.180 |
Why?
|
| Gallium Radioisotopes | 1 | 2019 | 154 | 0.180 |
Why?
|
| Receptors, AMPA | 1 | 2020 | 349 | 0.170 |
Why?
|
| Acetates | 1 | 2019 | 309 | 0.160 |
Why?
|
| Peptides, Cyclic | 1 | 2020 | 415 | 0.160 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 26 | 0.150 |
Why?
|
| Hydrogen Bonding | 1 | 2016 | 299 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2020 | 886 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2020 | 5542 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 8600 | 0.130 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 552 | 0.130 |
Why?
|
| Flavones | 1 | 2014 | 63 | 0.130 |
Why?
|
| Hydrazones | 1 | 2014 | 107 | 0.130 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2014 | 1603 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4329 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 2043 | 0.120 |
Why?
|
| Camptothecin | 1 | 2016 | 554 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2020 | 3243 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 2816 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 34503 | 0.110 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 377 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 293 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 630 | 0.100 |
Why?
|
| Rats | 4 | 2022 | 25092 | 0.100 |
Why?
|
| tau Proteins | 1 | 2021 | 1645 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 722 | 0.100 |
Why?
|
| Lactones | 1 | 2013 | 337 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3615 | 0.090 |
Why?
|
| Cysteine | 1 | 2014 | 871 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2013 | 1900 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6676 | 0.090 |
Why?
|
| Dipeptides | 1 | 2010 | 412 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2015 | 1674 | 0.080 |
Why?
|
| Animals | 8 | 2022 | 170894 | 0.080 |
Why?
|
| Lipids | 2 | 2015 | 3269 | 0.080 |
Why?
|
| Thrombosis | 1 | 2020 | 2860 | 0.070 |
Why?
|
| Diterpenes | 1 | 2006 | 179 | 0.070 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 2020 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2015 | 1942 | 0.060 |
Why?
|
| Temperature | 1 | 2010 | 2161 | 0.060 |
Why?
|
| Mice | 5 | 2021 | 81128 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 717280 | 0.050 |
Why?
|
| Mice, Inbred ICR | 1 | 2021 | 378 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13301 | 0.050 |
Why?
|
| Autoradiography | 1 | 2021 | 794 | 0.050 |
Why?
|
| Amination | 1 | 2019 | 19 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9597 | 0.040 |
Why?
|
| Micelles | 1 | 2019 | 220 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5022 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2021 | 679 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 16989 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 2407 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 11276 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 218 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3933 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13754 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2336 | 0.030 |
Why?
|
| Male | 3 | 2021 | 351399 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 1476 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 776 | 0.030 |
Why?
|
| Polymers | 1 | 2019 | 1630 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2010 | 41 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 20572 | 0.030 |
Why?
|
| Water | 1 | 2016 | 1339 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 629 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1616 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3830 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 3213 | 0.020 |
Why?
|
| Protein Binding | 1 | 2021 | 9665 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9927 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3697 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 6142 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 6133 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 15258 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2234 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22929 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 7259 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5271 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58528 | 0.010 |
Why?
|
| Female | 1 | 2015 | 377934 | 0.000 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_